DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
<p>The classification of calcium antagonists is presented. There were considered the results of large randomized trials, which were devoted to study of influence of dihydropyridine calcium antagonists on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-12-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | http://www.rpcardio.ru/jour/article/view/386 |
id |
doaj-3c2c40d170ca45c2bf24429590072aae |
---|---|
record_format |
Article |
spelling |
doaj-3c2c40d170ca45c2bf24429590072aae2020-11-25T00:19:08ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-12-0131555910.1234/1819-6446-2007-1-55-59386DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USES. Y. Martsevich0Государственный научно-исследовательский центр профилактической медицины Роздрава, Москва<p>The classification of calcium antagonists is presented. There were considered the results of large randomized trials, which were devoted to study of influence of dihydropyridine calcium antagonists on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists in modern recommendations on treatment of arterial hypertension and ischemic heart disease is defined. The clinical importance of differences between various presentations of dihy-dropyridine calcium antagonists is stressed.</p>http://www.rpcardio.ru/jour/article/view/386антагонисты кальциядигидропиридинысердечно-сосудистые осложненияартериальная гипертонияишемическая болезнь сердца |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
S. Y. Martsevich |
spellingShingle |
S. Y. Martsevich DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE Racionalʹnaâ Farmakoterapiâ v Kardiologii антагонисты кальция дигидропиридины сердечно-сосудистые осложнения артериальная гипертония ишемическая болезнь сердца |
author_facet |
S. Y. Martsevich |
author_sort |
S. Y. Martsevich |
title |
DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE |
title_short |
DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE |
title_full |
DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE |
title_fullStr |
DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE |
title_full_unstemmed |
DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE |
title_sort |
dihydropyridine calcium antagonists: data of evidence based medicine and recom-mendations on practical use |
publisher |
Stolichnaya Izdatelskaya Kompaniya |
series |
Racionalʹnaâ Farmakoterapiâ v Kardiologii |
issn |
1819-6446 2225-3653 |
publishDate |
2015-12-01 |
description |
<p>The classification of calcium antagonists is presented. There were considered the results of large randomized trials, which were devoted to study of influence of dihydropyridine calcium antagonists on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists in modern recommendations on treatment of arterial hypertension and ischemic heart disease is defined. The clinical importance of differences between various presentations of dihy-dropyridine calcium antagonists is stressed.</p> |
topic |
антагонисты кальция дигидропиридины сердечно-сосудистые осложнения артериальная гипертония ишемическая болезнь сердца |
url |
http://www.rpcardio.ru/jour/article/view/386 |
work_keys_str_mv |
AT symartsevich dihydropyridinecalciumantagonistsdataofevidencebasedmedicineandrecommendationsonpracticaluse |
_version_ |
1725373128880685056 |